Medical Aesthetics Market: Growth, Size, Share, and Trends

Report Code MD 4793
Published in Dec, 2024, By MarketsandMarkets™
Download PDF

Choose License Type

Buy Report Now Inquire Before Buying

Medical Aesthetics Market by Product (Botox, Filler, Peel, Implant, Liposuction, Microneedling, Hair Removal, Laser Resurfacing, RF, Phototherapy), Procedure (Surgical, Nonsurgical), End User (Hospital, Beauty Clinic, Spa), Region - Global Forecast to 2030

Overview

The medical aesthetics market is projected to reach USD 35.32 billion by 2030 from USD 17.16 billion in 2024, at a CAGR of 12.8% from 2024 to 2030. The medical aesthetics market has gained momentum with the advancement in aesthetic treatments and the growing acceptance of minimally and non-invasive cosmetic procedures. Increasing disposable incomes, a growing preference for medical aesthetics procedures, and an aging population are attributed to the growing demand for medical aesthetics products and procedures. Technological advancements in energy-based devices, such as laser and ultrasound, are among the key market drivers.

Medical aesthetics Market

Attractive Opportunities in the Medical aesthetics Market

North America

The North America region is expected to grow at the maximum CAGR over the forecast period as economic healthcare spending coupled with growing hospital establishment and advancement in healthcare infrastructure supports the adoption of advanced medical aesthetics treatments.

Intensified research and development efforts by key companies have resulted in the creation and introduction of innovative products.

Rising the disposable income leading the adoptions of medical aesthetics product in North America.

In the realm of medical aesthetic devices, Canada stands as the second-largest market in North America. The escalation in aesthetic procedures, the introduction of cutting-edge RF- and laser- based products.

North America holds the largest share of the medical aesthetics market, mainly due to the high volume of aesthetic procedures performed, an aging population, growing awareness, and government support for healthcare infrastructure.

Global Medical aesthetics Market Dynamics

DRIVER: Rising demand for minimally and non-invasive aesthetic procedures

The preference for less invasive and non-surgical aesthetic treatments is very strong in the medical aesthetic market. Botox, dermal fillers, laser therapies, chemical peels, and microdermabrasion are some of the treatments that have become effective means of addressing widespread aesthetic concerns, albeit with much reduced risk and recovery time compared to traditional surgery. An ISAPS 2023 report suggests the growing demand for non-invasive procedures worldwide is fueled by technological advancement, increased consumer awareness, and the rising focus on natural results.

These treatments have minimal downtime, so patients return to their normal lives as quickly as possible. Convenience is a particularly attractive factor for working professionals and other young populations who are looking for a quick but effective solution to revitalize their skin, wrinkle away, and enhance facial contours. In fact, more elderly populations are also starting to take these treatments as safer alternatives to the surgical option for anti-aging purposes.

Another significant factor making aesthetic procedures more popular is accessibility since the procedures are often less expensive than surgical interventions. Customized treatment programs make them attractive for personalized results to specific needs. The treatments reduce the possibilities of scarring, a huge concern for individuals who may fear or be reluctant to undergo surgical procedures.

RESTRAINT: Stringent regulatory compliance and safety standards in medical aesthetics

Medical aesthetics is heavily regulated for compliance and safety purposes, mainly in terms of ensuring patient safety and effective treatment results. These are certainly necessary to gain trust and maintain ethical practices but pose challenges for players in the market. Ensuring compliance and regulatory SOPs for medical aesthetics procedures is resource-intensive, especially for new entrants, as it demands a lot of investment in research, product testing, and documentation. A rigid regulatory framework makes the commercialization of new devices used in procedures more difficult, which can delimit the growth of the market.

The costs of compliance associated with regulation are also significant and push up the prices of treatment to end-users. Such regulations result in stiff oversight control from manufacturing processes to clinical testing and claims during marketing. Companies fail to live up to such standards and are open to severe fines, product recalls, or litigation that could damage their reputation and financial standing. Compliances are also very diverse across regions, with specific authorities such as the FDA in the US, CE marking in Europe, and country-specific approvals in Asia imposing different standards. These regulatory standards make manufacturers of medical aesthetics products more sensitized toward ensuring high-quality standards, which help to gain consumer and end-user satisfaction.

 

OPPORTUNITY: Growth opportunities in emerging economies

In emerging economies, the prospects for the medical aesthetics market are growing due to the changing socio-economic and demographic paradigms. Increased disposable incomes and expanding populations have increased the accessibility of cosmetic treatments. A report released by ISAPS in 2022 states that demand for treatments such as Botox and dermal fillers will increase based on changing beauty standards.

Emerging economies are destinations for medical tourism, offering affordable yet quality aesthetic treatment. India, Thailand, and Brazil attract international patients seeking cost-effective procedures through well-trained professionals and state-of-the-art technology. Relatively untapped markets in these regions leave much that can be exploited through new and existing market entrants based on partnerships established with local distributors and clinics.

Non-invasive and tailored laser treatments increase the effectiveness and desirability of treatment in these areas. National health infrastructure development programs and regulatory support for medical aesthetics also help in expanding the market. For instance, incentives such as technology transfer and tax benefits for healthcare investors have helped in growth.

However, they are required to face the challenge of regulatory compliances, differences in cultural setup, and volatile economic systems. Companies with products oriented toward local preferences, encouraging collaboration, and matching their business models to the range of regulatory frameworks find themselves squarely placed to compete within these promising markets that are forecasted to expand dramatically throughout the next decade.

CHALLENGES: Presence of alternative beauty and cosmetic products

Alternative beauty and cosmetic products will present a challenge to the medical aesthetics market. Consumers today are going to seek out convenient, affordable, and speedy over-the-counter products, which usually include topical creams, at-home devices, and so-called pain-free, non-invasive treatments that continue to grow the demand for home-based treatments. The global market for non-invasive products in the beauty industry is expected to rise more than 15% annually, fueled by lower costs and ease of application. This trend seems prevalent in the younger generation, as those are most sensitive to cost and look for instant gratification.

Professional aesthetic treatment providers face increasing competition, necessitating a stronger focus on the benefits of their services, such as long-term results, safety, and personalized care. To counter this competition, raising consumer awareness about the risks of unregulated or non-professional treatments and the advantages of professional care is essential. As the market becomes more saturated, medical aesthetics providers must highlight their expertise and offer highly personalized services to attract and retain customers effectively.

Global Medical aesthetics Market Ecosystem Analysis

The medical aesthetics market ecosystem comprises various components, including facial aesthetics solutions, body contouring devices, cosmetic implants, skin aesthetics devices, hair removal devices, tattoo removal devices, and nail treatment laser devices. These products are categorized into three main types: standalone devices, multimodal devices, and at-home/self-use devices. These products are provided with a comprehensive ecosystem comprising device providers, end users, and distributors.

Medical aesthetics Market
 

By product, the facial aesthetic products segment accounted for the largest share in 2023.

As of 2023, the facial aesthetic products segment had the highest market share in the medical aesthetics industry. This segment is driven by the increasing adoption of advanced tools that improve diagnostic precision and treatments offering enhanced sensitivity. They are accurate and have more tailored approaches to specific aesthetic problems, keeping track of the strong consumer demand for effective, non-invasive, and minimally invasive aesthetic solutions. Growing advancements in facial aesthetic technology, such as lasers, fillers, and Botox, which are highly accepted across all age groups, are also driving the segment. This will further bolster the facial aesthetic products to hold a strong market position as the industry continues to innovate and develop new treatment options for these largely prevalent conditions.

By procedure, the hair removal segment of the non-surgical procedures market will register significant growth in the near future.

Based on procedure, the medical aesthetics market is segmented into surgical procedures (breast augmentation, rhinoplasty, facelift and body lift, and other surgical procedures) and non-surgical procedures (anti-aging and skin rejuvenation, tattoo and scar removal, hair removal, liposuction, other non-surgical procedures). The liposuction segment of the non-surgical procedures segment market by procedure is expected to grow at the highest rate over the forecast period. Increasing adoption of innovative devices that allow precise targeting and real-time imaging in medical aesthetics are the chief factors contributing to the highest growth rate of the key drivers for the rapid growth of this segment.

In addition, the increasing popularity of minimally invasive treatments with short recovery periods enables further development of liposuction procedures. The advancement of non-invasive technologies, such as laser and cryoliposuction, led to increased demand for fat reduction treatments that patients can visibly see and receive without surgical intervention. This trend is further supported by enhanced patient awareness, greater availability of these procedures, and the growing preference for aesthetic enhancements in medical and cosmetic practices.

By end user, the clinics, hospitals, and medical spas segment accounted for the largest share in 2023.

Based on end user, the medical aesthetics market is segmented into clinics, hospitals, medical spas, beauty centers, and home care settings. In 2023, the clinics, hospitals, and medical spas segment accounted for the largest market share. This segment is seen to be highly attributed to the increasing usage of automated systems. The majority share of this segment is contributed by the increasing adoption of automated systems in medical aesthetics clinics for early disease detection, which is attributed to the increased awareness. This surge is primarily caused by the digitization of patient workflows in aesthetic practices and the rise in procedures undertaken in aesthetic lines, along with the increased implementation of advanced systems in these clinics to provide better patient care.

North America is expected to be the largest market during the forecast period.

The North American market, comprising the US and Canada, had the maximum share in the global medical aesthetics market in 2023. The region is recording rapid growth catalyzed by various factors, such as the inclusion of medical aesthetics within the healthcare system. Health professionals are now taking up aesthetic treatments, so there is a growing demand for advanced technologies in procedures such as body contouring, skin rejuvenation, and laser treatments. Positive reimbursement policies are encouraging such treatments.

The presence of companies such as Allergan (US), Galderma (Switzerland), and Merz Pharmaceuticals (Germany) has given rise to the increasingly growing market since it provides products and services repeatedly and innovatively. Another major factor for this market is the growing elderly population, as the demographics are rapidly soaring, and they require anti-aging and rejuvenation solutions for their skin. Other factors driving this market momentum are establishing more aesthetically pleasing imaging centers and specialty clinics in the region, thus making the services more accessible to an even more significant population. In this regard, North America positions itself as a dominant force in the global market for medical aesthetics.

HIGHEST CAGR MARKET IN 2024-2030
CHINA FASTEST GROWING MARKET IN THE REGION
Medical aesthetics Market

Recent Developments of Medical aesthetics Market

  • In October 2024, Allergan Aesthetics, part of AbbVie Inc. (US), gained FDA approval for BOTOX Cosmetic to address moderate to severe platysma bands, which are the vertical bands linking the jaw and neck.
  • In January 2024, Galderma (Switzerland) received regulatory approval for Restylane SHAYPE, a hyaluronic acid injectable designed to enhance the chin area, providing a bone-like effect for shaping the lower face. It uses NASHA HD technology to deliver natural-looking, long-lasting results for up to 12 months.
  • In May 2023, AbbVie Inc. obtained FDA approval for SKINVIVE by JUVÉDERM, an innovative hyaluronic acid (HA) intradermal microdroplet injection to improve cheek skin smoothness in adults aged 21 and older.
  • In April 2023, Galderma announced the FDA-approved Sculptra (injectable poly-L-lactic acid, PLLA-SCA) to correct fine lines and wrinkles in the cheek area.

Key Market Players

Want to explore hidden markets that can drive new revenue in Medical Aesthetics Market?

Scope of the Report

Report Metric Details
Market size available for years 2022-2030
Base Year Considered 2023
Forecast period 2024-2030
Forecast units Value (USD Million/USD Billion)
Segments covered Product, Device Type, Procedure, End User, and Region
Geographies covered North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa

 

Key Questions Addressed by the Report

What is the expected addressable market value of the global medical aesthetics market for six years from now?
The market will reach USD 35.3 billion by 2030 from USD 17.1 billion in 2024, at a CAGR of 12.8%.
Which segment under the product category is anticipated to gain the highest traction in the medical aesthetics market?
The facial aesthetics product segment is expected to grow at the highest share.
What strategies are adopted by the top market players to penetrate emerging economies?
Partnerships, distribution agreements, product launches, and product approvals are key growth tactics.
What factors can delimit the growth of the medical aesthetics market?
Stringent regulations, high treatment costs, limited reimbursement, post-surgery infection risks, and potential side effects.
Which are the top players in the medical aesthetics market?
AbbVie Inc., Alma Lasers, Cynosure Lutronic, Johnson & Johnson Services, Bausch Health Companies, Cutera, Galderma, El.En. S.p.A., and InMode Ltd.
In terms of end-users, which segment is expected to gain the highest traction in the medical aesthetics market?
Clinics, hospitals, and medical spas are expected to grow at the highest rate.
What are the emerging trends in the market for medical aesthetics products and procedures?
Non-invasive treatments (injectables, laser procedures), personalized treatments guided by AI, body contouring, and holistic wellness approaches.

 

Personalize This Research

  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
Request A Free Customisation

Let Us Help You

  • What are the Known and Unknown Adjacencies Impacting the Medical Aesthetics Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
Customized Workshop Request

Table of Contents

Exclusive indicates content/data unique to MarketsandMarkets and not available with any competitors.

TITLE
PAGE NO
INTRODUCTION
1
RESEARCH METHODOLOGY
17
EXECUTIVE SUMMARY
35
PREMIUM INSIGHTS
67
MARKET OVERVIEW
89
  • 5.1 MARKET DYNAMICS
    DRIVERS
    RESTRAINTS
    KEY GROWTH OPPORTUNITIES
    INDUSTRY-SPECIFIC CHALLENGES
  • 5.2 PORTER’S FIVE FORCES ANALYSIS
  • 5.3 REGULATORY LANDSCAPE
    REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANISATIONS
    REGULATORY FRAMEWORK
  • 5.4 ECOSYSTEM MARKET MAP
  • 5.5 VALUE CHAIN ANALYSIS
  • 5.6 SUPPLY CHAIN ANALYSIS
  • 5.7 PRICING ANALYSIS
    AVERAGE SELLING PRICE OF KEY PLAYERS, BY PRODUCT TYPE (USD, 2023)
    AVERAGE SELLING PRICE TREND, BY PRODUCT TYPE, BY REGION (USD, 2021 – 2023)
  • 5.8 PATENT ANALYSIS
  • 5.9 TRADE ANALYSIS
  • 5.10 TECHNOLOGY ANALYSIS
    KEY TECHNOLOGIES
    - LASER AND LIGHT-BASED TECHNOLOGIES
    - RADIOFREQUENCY (RF) TECHNOLOGY
    - ULTRASOUND TECHNOLOGY
    COMPLIMENTARY TECHNOLOGIES
    - AI-POWERED SKIN ANALYSIS SYSTEMS
    ADJACENT TECHNOLOGIES
    - REGENERATIVE MEDICINE AND STEM CELL THERAPY
  • 5.11 KEY CONFERENCES & EVENTS IN 2025-2026
  • 5.12 TRENDS/DISRUPTIONS IMPACTING CUSTOMER’S BUSINESS
  • 5.13 KEY STAKEHOLDERS AND BUYING CRITERIA
    KEY STAKEHOLDERS IN THE BUYING PROCESS
    BUYING CRITERIA
  • 5.14 CASE STUDY ANALYSIS
  • 5.15 UNMET NEEDS/END USER EXPECTATIONS IN MEDICAL AESTHETICS MARKET
  • 5.16 ADJACENT MARKET ANALYSIS
  • 5.17 INVESTMENT AND FUNDING SCENARIO
  • 5.18 AI IN MEDICAL AESTHETICS MARKET
MEDICAL AESTHETICS MARKET DATA, BY PRODUCT (USD MILLION; 2022—2030)
96
  • 6.1 FACIAL AESTHETICS PRODUCTS
    BOTULINUM TOXIN
    DERMAL FILLERS
    - NATURAL DERMAL FILLERS
    - SYNTHETIC DERMAL FILLERS
    CHEMICAL PEELS
    MICRODERMABRASION
  • 6.2 BODY CONTOURING DEVICES
    NON-SURGICAL FAT REDUCTION DEVICES
    CELLULITE REDUCTION DEVICES
    LIPOSUCTION DEVICES
  • 6.3 COSMETICS IMPLANTS
    BREAST IMPLANTS
    - SILICONE BREAST IMPLANTS
    - SALINE BREAST IMPLANTS
    FACIAL IMPLANTS
    OTHER COSMETIC IMPLANTS
  • 6.4 PHYSICIAN-DISPENSED COSMECEUTICALS AND SKIN LIGHTENERS
  • 6.5 SKIN AESTHETICS DEVICES
    LASERS SKIN RESURFACING DEVICES
    NON-SURGICAL SKIN TIGHTENING DEVICES
    MICRONEEDLING PRODUCTS
    LIGHT THERAPY DEVICES
  • 6.6 PHYSICIAN-DISPENSED EYELASH PRODUCTS
  • 6.7 HAIR REMOVAL DEVICES
    LASERS REMOVAL DEVICES
    IPL HAIR REMOVAL DEVICES
  • 6.8 TATTOO REMOVAL DEVICES
  • 6.9 THREAD LIFT PRODUCTS
  • 6.10 NAIL TREATMENT LASER DEVICES
MEDICAL AESTHETICS MARKET DATA, BY PRODUCT TYPE (USD MILLION; 2022—2030)
115
  • 7.1 STANDALONE DEVICES
  • 7.2 MULTIMODAL DEVICES
  • 7.3 AT-HOME/SELF USE DEVICES
MEDICAL AESTHETICS MARKET DATA, BY PROCEDURE (USD MILLION; 2022—2030)
167
  • 8.1 NON-SURGICAL PROCEDURES
    ANTI-AGING AND SKIN REJUVENATION
    TATTOO REMOVAL
    HAIR REMOVAL
    LIPOLYSIS
    OTHER NON-SURGICAL PROCEDURES
  • 8.2 SURGICAL PROCEDURES
    BREAST AUGMENTATION
    FACELIFT AND BODYLIFT
    OTHER SURGICAL PROCEDURES
MEDICAL AESTHETICS MARKET DATA, BY END-USERS (USD MILLION; 2022—2030)
198
  • 9.1 CLINICS, HOSPITALS, AND MEDICAL SPAS
  • 9.2 BEAUTY CENTERS
  • 9.3 HOME CARE SETTINGS
MEDICAL AESTHETICS MARKET DATA, BY REGION (USD MILLION; 2022—2030)
207
  • 10.1 INTRODUCTION
  • 10.2 NORTH AMERICA
    MACROECONOMIC OUTLOOK FOR NORTH AMERICA
    US
    CANADA
  • 10.3 EUROPE
    MACROECONOMIC OUTLOOK FOR EUROPE
    GERMANY
    UK
    FRANCE
    ITALY
    SPAIN
    REST OF EUROPE
  • 10.4 ASIA-PACIFIC
    MACROECONOMIC OUTLOOK FOR ASIA-PACIFIC
    CHINA
    JAPAN
    INDIA
    SOUTH KOREA
    AUSTRALIA
    REST OF ASIA-PACIFIC
  • 10.5 LATIN AMERICA
    MACROECONOMIC OUTLOOK FOR LATIN AMERICA
    BRAZIL
    MEXICO
    REST OF LATIN AMERICA
  • 10.6 MIDDLE EAST & AFRICA
    MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA
    GCC COUNTRIES
    REST OF MIDDLE EAST AND AFRICA
COMPETITIVE LANDSCAPE
245
  • 11.1 INTRODUCTION
  • 11.2 KEY PLAYER STRATEGIES/RIGHT TO WIN (2021-2024)
  • 11.3 REVENUE ANALYSIS
  • 11.4 MARKET SHARE ANALYSIS BY KEY PLAYERS, 2023
    MEDICAL AESTHETICS MARKET
  • 11.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023
    STARS
    EMERGING LEADERS
    PERVASIVE PLAYERS
    PARTICIPANTS
    - COMPANY FOOTPRINT
    - PRODUCT FOOTPRINT
    - PRODUCT TYPE FOOTPRINT
    - PROCEDURE FOOTPRINT
    - END-USER FOOTPRINT
    - REGION FOOTPRINT
  • 11.6 COMPANY EVALUATION MATRIX:STARTUPS/SMES, 2023
    PROGRESSIVE COMPANIES
    RESPONSIVE COMPANIES
    DYNAMIC COMPANIES
    STARTING BLOCKS
    COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2023
    - DETAILED LIST OF KEY STARTUPS/SMES
    - COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES
  • 11.7 C0OMPETITIVE SITUATION AND TRENDS (2021-2024)
    NEW PRODUCT LAUNCHES & APPROVALS
    DEALS
    OTHER DEVELOPMENTS
  • 11.8 BRAND/PRODUCT COMPARATIVE ANALYSIS
  • 11.9 R&D ASSESSMENT OF KEY PLAYERS
  • 11.10 COMPANY VALUATION AND FINANCIAL METRICS
COMPANY PROFILES**
267
  • 12.1 KEY PLAYERS
    ABBVIE INC
    ALMA LASERS
    AEROLASE CORP
    ANIKA THERAPEUTICS, INC.
    ASCLEPION
    ASTANZA LASER LLC
    APYX MEDICAL
    BAUSCH HEALTH COMPANIES INC
    BOHUS BIOTECH AB
    CUTERA
    CYNOSURE LUTRONIC
    CANDELA CORPORATION
    EL. EN S.P.A
    FOTONA
    GC AESTHETICS
    GALDERMA
    HUADONG MEDICINE CO LTD
    INMODE LTD
    JOHNSON & JOHNSON MEDICAL LIMITED
    LUMENIS BE LTD.
    MERZ PHARMA
    MEDYTOX
    POLYTECH HEALTH & AESTHETICS GMBH
    PHOTOMEDEX
    RECOSMO
    REVANCE AESTHETICS
    SHARPLIGHT TECHNOLOGIES INC
    SCITON
    SINCLAIR
    VENUS CONCEPT
APPENDIX
289

Four primary studies have been undertaken to size the medical aesthetics market. Secondary research has been used to obtain preliminary data for the medical aesthetics market and peer and parent markets. Data were collected from 3-5 secondary sources, and validated by primary sources for assumptions and market sizing. Through top-down and bottom-up approaches, the overall market size was informed and further broken down, and data was triangulated for segment and subsegment sizing.

Secondary Research

These included directories, Factiva, white papers, Bloomberg Businessweek, annual reports, SEC filings, business filings, and investor presentations, among others Through these souces, one can gain critical data about market leaders, how the industry is divided into sectors, and how technology varies from one industry level to another within medical aesthetics.

Primary Research

Primary research consisted of interviewing people from the supply side of the business and the demand side to get quantitative and qualitative insights. On the demand side, primary sources involved in the study included physicians, researchers, department heads, staff from diagnostic centers, hospital staff, and those attached to the research institutes, while on the supply side, it involved CEOs, area sales managers, territory and regional sales managers, and various other top executives of relevant companies. These direct meetings with people in key leadership positions helped validate assumptions arising from secondary research and bring them face-to-face so that any assumptions could also be directly

A breakdown of the primary respondents is provided below:

Medical aesthetics Market

*Others include sales managers, marketing managers, business development managers, product managers, distributors, and suppliers.

Note: Companies are classified into tiers based on their total revenue. As of 2023, Tier 1 = >USD 1 billion, Tier 2 = < USD 500 million, and Tier 3 = < USD 100 million.

To know about the assumptions considered for the study, download the pdf brochure

Market Size Estimation

The revenue share analysis of major companies was used in this report to determine the size of the global medical aesthetics market. This was accomplished by identifying the major market participants and calculating their medical aesthetics business revenues using a variety of information acquired throughout the primary and secondary research stages. Examining the annual and financial reports of the leading market participants was one aspect of secondary research. On the other hand, primary research involved in-depth interviews with important thought leaders, including directors, CEOs, and important marketing executives.

Segmental revenues were computed using the revenue mapping of the leading solution/service providers to determine the worldwide market value. The following steps were engaged in this process:

  • Making a list of the leading international companies in the medical aesthetics industry
  • Charting the annual profits made by the leading companies in the medical aesthetics sector (or the closest stated business unit/product category)
  • As of 2023, revenue mapping of leading companies to cover a significant portion of the global market
  • Calculating the medical aesthetics industry's global value

Global Medical aesthetics Market: Bottom-up and Top-down approach

Medical aesthetics Market

Data Triangulation

After determining the overall market size through the process of estimation as discussed above, the global medical aesthetics market has been segmented and subsegmented. Data triangulation and market breakdown methods have been used to refine the accuracy of these estimates. This process is based on the analysis of multiple factors and trends from both the demand and supply perspectives. The medical aesthetics market has been validated through both the top-down and bottom-up approaches, ensuring the accuracy of the segment and subsegment statistics.

Market Definition

The medical aesthetics market comprises a broad scope of nonsurgical and minimally invasive treatments and products to improve the aesthetic appearance of an individual. Such procedures are usually aimed at issues concerning skin, body, and dental appearance and are specifically customized to meet individual needs. The use of advanced technologies makes it possible to rejuvenate, contour the body, and enhance dental aesthetics.

Applications under this medical aesthetics market include facial aesthetics, body shaping, skin rejuvenation, hair removal, scar reduction, and pigmentation correction. The market has several end customers, including dermatology and cosmetic clinics, hospitals, beauty centers, medical spas, and even home device consumers.

Stakeholders

  • Medical Aesthetic Clinics
  • Cosmetic Product Manufacturers
  • Aesthetic Device Manufacturers
  • Pharmaceutical Companies
  • Hospitals and Surgical Centers
  • Aesthetic Product Retailers
  • Medical Spas and Beauty Spas
  • Cosmetologists and Plastic Surgeons
  • Media and Influencers
  • Medical Aesthetics Device Distributors and Suppliers
  • Market Research and Consulting Firms

Report Objectives

  • To define, describe, and forecast the medical aesthetics market based on product, device type, procedure, end user, and region
  • To provide detailed information regarding the major factors influencing the market growth (such as drivers, restraints, opportunities, and challenges)
  • To analyze the micro markets for individual growth trends, prospects, and contributions to the overall medical aesthetics market
  • To analyze the opportunities for stakeholders and provide details of the competitive landscape for market leaders
  • To forecast the size of the market segments for five regions, namely, North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa
  • To profile the key players and analyze their market shares and core competencies
  • To track and analyze competitive developments, such as product launches, funding and grants, partnerships, agreements, collaborations, expansions, strategic alliances, and acquisitions
  • To benchmark players within the market using the proprietary “Company Evaluation Matrix” framework to analyze players on various parameters within the broad categories of business and product excellence strategy.

Previous Versions of this Report

Medical Aesthetics Market by Product (Botox, Dermal Filler, Chemical Peel, Liposuction, Fat Reduction, Skin Tightening, Breast Implant, Hair/Tattoo Removal, Thread Lift, Nail Treatment), End User (Medical Spa, Beauty Center) & Region - Global Forecast to 2027

Report Code MD 4793
Published in Sep, 2023, By MarketsandMarkets™

Medical Aesthetics Market by Product (Botox, Dermal Filler, Chemical Peel, Liposuction, Fat Reduction, Skin Tightening, Breast Implant, Hair/Tattoo Removal, Thread Lift, Nail Treatment), End User (Medical Spa, Beauty Center) - Global Forecast to 2027

Report Code MD 4793
Published in Sep, 2022, By MarketsandMarkets™

Medical Aesthetics Market Product (Botox, Dermal Filler, Liposuction, Cellulite Reduction, Fat Reduction, Skin Tightening, Breast Implant, Tattoo Removal, Thread Lift), End User (Clinic, Medical Spa, Hospital, Beauty Center) - Global Forecast to 2025

Report Code MD 4793
Published in Aug, 2020, By MarketsandMarkets™

Medical Aesthetics Market Product (Botox, Dermal Filler, Liposuction, Cellulite Reduction, Fat Reduction, Skin Tightening, Breast Implant, Tattoo Removal, Thread Lift), End User (Clinic, Medical Spa, Hospital, Beauty Center) - Global Forecast to 2023

Report Code MD 4793
Published in Sep, 2018, By MarketsandMarkets™

Medical Aesthetics Market Product (Botox, Dermal Filler, Liposuction, Cellulite Reduction, Fat Reduction, Skin Tightening, Breast Implant, Tattoo Removal, Thread Lift), End User (Clinic, Medical Spa, Hospital, Beauty Center) - Global Forecast to 2023

Report Code MD 4793
Published in Sep, 2018, By MarketsandMarkets™

Medical Aesthetics Market by Product (Liposuction, Cellulite & Fat Reduction, Skin Tightening, Breast Implants, Botox, Dermal Fillers, Tattoo Removal, Thread Lift, Laser Hair Removal), End-User (Clinics & Medical Spas, Beauty Center) - Forecast to 2021

Report Code BT 3469
Published in Nov, 2016, By MarketsandMarkets™

Medical Aesthetics Market by Products (Liposuction, Cellulite Reduction, Fat Reduction, Skin Tightening, Breast Implants, Botox, Dermal Fillers), Procedures (Cosmetic & Reconstructive), & End-Users (Beauty center and Home) - Global Forecast to 2020

Report Code BT 3469
Published in Jun, 2015, By MarketsandMarkets™
"Our USP is "providing game-changing business opportunities reports with free customization" - so please feel free to provide us with your specific areas of interest / business challenges in much greater detail !!"

We appreciate your interest in this report. Once you fill out the form, you'll be immediately directed to an exclusive solution tailored to your needs. This high-value offering can help boost your revenue by 30% - a must-see opportunity for anyone looking to maximize growth.


By clicking the "Submit" button, you are agreeing to the Terms of Use and Privacy Policy.

Custom Market Research Services

We Will Customise The Research For You, In Case The Report Listed Above Does Not Meet With Your Requirements

Get 10% Free Customisation

Growth opportunities and latent adjacency in Medical Aesthetics Market

DMCA.com Protection Status